R&D | January 21, 2026
Moderna & Merck study: mRNA therapy plus KEYTRUDA cut melanoma recurrence risk by half
The study evaluated patients with stage III/IV melanoma after complete tumor resection
The study evaluated patients with stage III/IV melanoma after complete tumor resection
India in the Changing Landscape of Life-Sciences Research & Development
The AI Nurse Companion, designed as a language-first learning platform, allows students to gain real-world German language proficiency through immersive practice
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
The combination also outperformed chemotherapy on another important secondary endpoint
The approvals target adult MIBC patients who are ineligible for cisplatin-based chemotherapy
_256_384.png)
Over 700 exhibitors from APAC, Europe, the US, and beyond showcased the latest in personal care innovation
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
The submissions are supported by data from the Phase 3 KEYNOTE-905 trial
Subscribe To Our Newsletter & Stay Updated
